Apellis Pharmaceuticals Inc., (Nasdaq: APLS) announced that it has commenced an underwritten public offering of $75 million of shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE